Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Limits to Personalized Cancer Medicine.

Literature DB >> 27682039

Limits to Personalized Cancer Medicine.

Ian F Tannock¹, John A Hickman¹.

Abstract

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 2016 PMID： 27682039 DOI： 10.1056/NEJMsb1607705

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

114 in total

Review 1. Precision Medicine for Heart Failure: Lessons From Oncology.

Authors: Arthur M Feldman; Christopher D Kontos; Joseph M McClung; Glenn S Gerhard; Kamel Khalili; Joseph Y Cheung
Journal: Circ Heart Fail Date: 2017-06 Impact factor: 8.790

2. The Radiation Stress Response: Of the People, By the People and For the People.

Authors: C Norman Coleman
Journal: Radiat Res Date: 2017-01-24 Impact factor: 2.841

Review 3. Implementing Genome-Driven Oncology.

Authors: David M Hyman; Barry S Taylor; José Baselga
Journal: Cell Date: 2017-02-09 Impact factor: 41.582

4. Precision Oncology beyond Targeted Therapy: Combining Omics Data with Machine Learning Matches the Majority of Cancer Cells to Effective Therapeutics.

Authors: Michael Q Ding; Lujia Chen; Gregory F Cooper; Jonathan D Young; Xinghua Lu
Journal: Mol Cancer Res Date: 2017-11-13 Impact factor: 5.852

Review 5. Applications of molecular engineering in T-cell-based immunotherapies.

Authors: David A McBride; Matthew D Kerr; Shinya L Wai; Nisarg J Shah
Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol Date: 2019-04-10

6. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).

Authors: J Mateo; D Chakravarty; R Dienstmann; S Jezdic; A Gonzalez-Perez; N Lopez-Bigas; C K Y Ng; P L Bedard; G Tortora; J-Y Douillard; E M Van Allen; N Schultz; C Swanton; F André; L Pusztai
Journal: Ann Oncol Date: 2018-09-01 Impact factor: 32.976

Limits to Personalized Cancer Medicine.

Review 1. Precision Medicine for Heart Failure: Lessons From Oncology.

2. The Radiation Stress Response: Of the People, By the People and For the People.

Review 3. Implementing Genome-Driven Oncology.

4. Precision Oncology beyond Targeted Therapy: Combining Omics Data with Machine Learning Matches the Majority of Cancer Cells to Effective Therapeutics.

Review 5. Applications of molecular engineering in T-cell-based immunotherapies.

6. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).

7. Patient-Paired Sample Congruence Between 2 Commercial Liquid Biopsy Tests.

8. Precision Medicine: Where have we reached and where are we headed?

9. Emerging Trends in Clinical Research: With Implications for Population Health and Health Policy.

Review 10. Personalized Cancer Models for Target Discovery and Precision Medicine.